Newstral
Article
Forbes on 2024-03-12 16:10
What To Know About Adcetris—Pfizer’s Cancer Drug Extended Survival For Patients With Common Lymphoma
Related news
- NPfizer’s expiry date extendednews.thevoicebw.com
- First patients in Israel receive Pfizer’s coronavirus-fighting pilltimesofisrael.com
- Pfizer’s Latest Covid Breakthroughwsj.com
- TThe risks of Pfizer’s COVID-19 vaccine for patients with a history of severe allergiestheconversation.com
- World’s Most Interesting Person – Pfizer’s Albert BourlaForbes
- Pregnancy warning extended for common pain relievers, FDA saysFox News
- New treatment helps extend survival for brain tumor patientsreviewjournal.com
- Aspirin Improves Survival For Hospitalized Covid Patients, Study FindsForbes
- The F.D.A. cleared Pfizer’s Covid pill, the first of its kind, for high-risk patients 12 and over.The New York Times
- MFDA approves Genentech's Polivy as part of first chemoimmunotherapy regimen for patients with diffuse large B-cell lymphomamarketwatch.com
- FDA approves Pfizer’s COVID-19 vaccine, now called ComirnatyArs Technica
- US regulators confirm Pfizer’s positive assessment of its vaccineAlaska Dispatch News
- US angling to secure more of Pfizer’s coronavirus vaccineMerced Sun-Star
- Pfizer’s Paxlovid not included in China’s national insurancejournalrecord.com
- Pfizer’s COVID-19 antiviral pill 89% effective against hospitalizationnewatlas.com